These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19427876

  • 1. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
    Sheng Z, Liang Z, Geiger JH, Prorok M, Castellino FJ.
    Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
    [Abstract] [Full Text] [Related]

  • 2. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
    Sheng Z, Prorok M, Castellino FJ.
    Neuroscience; 2010 Oct 27; 170(3):703-10. PubMed ID: 20688135
    [Abstract] [Full Text] [Related]

  • 3. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC, Prorok M, Galdzicki Z, Castellino FJ.
    J Biol Chem; 2001 Jul 20; 276(29):26860-7. PubMed ID: 11335724
    [Abstract] [Full Text] [Related]

  • 4. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
    Sheng Z, Dai Q, Prorok M, Castellino FJ.
    Neuropharmacology; 2007 Jul 20; 53(1):145-56. PubMed ID: 17588620
    [Abstract] [Full Text] [Related]

  • 5. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
    Ragnarsson L, Yasuda T, Lewis RJ, Dodd PR, Adams DJ.
    J Neurochem; 2006 Jan 20; 96(1):283-91. PubMed ID: 16336218
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T, Mirshahi T, Chandler LJ, Woodward JJ.
    J Neurochem; 1997 Dec 20; 69(6):2345-54. PubMed ID: 9375665
    [Abstract] [Full Text] [Related]

  • 7. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
    Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B, Betz H.
    Neuropharmacology; 2001 Nov 20; 41(6):753-61. PubMed ID: 11640930
    [Abstract] [Full Text] [Related]

  • 8. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K.
    Mol Pharmacol; 1993 Oct 20; 44(4):851-9. PubMed ID: 7901753
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L, Cardullo F.
    J Pharmacol Exp Ther; 2010 Dec 20; 335(3):636-44. PubMed ID: 20810618
    [Abstract] [Full Text] [Related]

  • 10. Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.
    Balsara R, Li N, Weber-Adrian D, Huang L, Castellino FJ.
    Neuropharmacology; 2012 Jun 20; 62(7):2227-38. PubMed ID: 22306487
    [Abstract] [Full Text] [Related]

  • 11. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.
    Xiao C, Huang Y, Dong M, Hu J, Hou S, Castellino FJ, Prorok M, Dai Q.
    Neuropeptides; 2008 Jun 20; 42(5-6):601-9. PubMed ID: 18992939
    [Abstract] [Full Text] [Related]

  • 12. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.
    Twede VD, Teichert RW, Walker CS, Gruszczyński P, Kaźmierkiewicz R, Bulaj G, Olivera BM.
    Biochemistry; 2009 May 19; 48(19):4063-73. PubMed ID: 19309162
    [Abstract] [Full Text] [Related]

  • 13. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF, Wyllie DJ.
    J Physiol; 2008 Jan 01; 586(1):227-45. PubMed ID: 17962328
    [Abstract] [Full Text] [Related]

  • 14. Factors that enhance ethanol inhibition of N-methyl-D-aspartate receptors in cerebellar granule cells.
    Popp RL, Lickteig RL, Lovinger DM.
    J Pharmacol Exp Ther; 1999 Jun 01; 289(3):1564-74. PubMed ID: 10336554
    [Abstract] [Full Text] [Related]

  • 15. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME, White HS, Wilcox KS.
    Epilepsy Res; 2004 Mar 01; 59(1):13-24. PubMed ID: 15135163
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors.
    Brimecombe JC, Boeckman FA, Aizenman E.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):11019-24. PubMed ID: 9380752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conantokins: peptide antagonists of NMDA receptors.
    Layer RT, Wagstaff JD, White HS.
    Curr Med Chem; 2004 Dec 30; 11(23):3073-84. PubMed ID: 15579001
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
    Klein RC, Galdzicki Z, Castellino FJ.
    Neuropharmacology; 1999 Dec 30; 38(12):1819-29. PubMed ID: 10608277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.